AstraZeneca. (n.d). AstraZeneca Global Site. Retrieved from: Htps://www.astrazeneca.com/. [Accessed December 11, 2018].
AstraZeneca Plc. (2019). Fort Mill: Mergent. Retrieved from: https://search.proquest.com/docview/1860788304?accountid=29916.
Bayer. (2019). Our political principles and positions. Retrieved from: https://www.bayer.com/en/political-principles-and-positions.aspx. [Accessed October 27, 2019].
Bayer. (n.d). Bayer company official website. Retrieved from: http://www.bayer.com/. [Accessed December 11, 2018].
Beaudry, P., & Portier, F. (2006). Stock prices, news, and economic fluctuations. American Economic Review, 96(4), 1293-1307.Available at: https://doi.org/10.1257/aer.96.4.1293.
Beaulieu, M.-C., Cosset, J.-C., & Essaddam, N. (2006). Political uncertainty and stock market returns: Evidence from the 1995 Quebec referendum. Canadian Journal of Economics, 39(2), 621-642.Available at: https://doi.org/10.1111/j.0008-4085.2006.00363.x.
Benartzi, S., & Thaler, R. H. (1995). Myopic loss aversion and the equity premium puzzle. The Quarterly Journal of Economics, 110(1), 73-92.
Benartzi., S., & Thaler, R. H. (1999). Risk aversion or myopia? Choices in repeated gambles and retirement investments. Management Science, 45(3), 364-381.
Beynon, K., & Porter, A. (2000). Valuing pharmaceutical companies: A guide to the assessment and evaluation of assets, performance and prospects. Cambridge: Woodhead.
Bloom, N., Bunn, P., Chen, S., Mizen, P., Smietanka, P., Thwaites, G., & Young, G. (2019a). Brexit and uncertainty: Insights from the decision maker panel. Bank of England Working Paper No. 780.
Bloom, N., Bunn, P., Chen, S., Mizen, P., Smietanka, P., Thwaites, G., & Young, G. (2019b). The impact of brexit on UK firms: Reduced investments and decreased productivity. NBER Working Paper No. 26218.
Born, B., Müller, G., Schularick, M., & Sedlacek, P. (2017). The economic consequences of the brexit vote. Discussion Papers No.1738, Centre for Macroeconomics (CFM).
Breinlich, H., Leromain, E., Novy, D., Sampson, T., & Usman, A. (2018). The economic effects of Brexit: Evidence from the stock market. Fiscal Studies, 39(4), 581-623.
Brett, D. (2017). Why stockmarkets rise when currencies fall. March 2017. Retrieved from https://www.schroders.com/en/mt/professional-investor/insights/markets/how-indexes-rise-when-currencies-fall--explained-in-two-charts/. [Accessed December 11, 2018].
Christie, A. A. (1982). The stochastic behavior of common stock variances: Value, leverage and interest rate effects. Journal of Financial Economics, 10(4), 407-432.Available at: https://doi.org/10.1016/0304-405x(82)90018-6.
CNNMoney. (n.d). Fear & greed index. Retrieved from: http://www.money.cnn.com. [Accessed December 11, 2018].
Davies, R., & Studnicka, Z. (2018). The heterogeneous impact of Brexit: Early indications from the FTSE. European Economic Review, 110, 1-17.Available at: https://doi.org/10.1016/j.euroecorev.2018.08.003.
De Bondt, W. F., & Thaler, R. (1985). Does the stock market overreact? The Journal of Finance, 40(3), 793-805.Available at: https://doi.org/10.2307/2327805.
European Federation of Pharmaceutical Industries and Associations. (2017). EFPIA brexit briefing. Retrieved from https://www.efpia.eu/media/288640/brexit-briefing-05122017.pdf. [Accessed September 27, 2018].
European Federation of Pharmaceutical Industries and Associations. (2019). The pharmaceutical industry in figures. Retrieved from: https://www.efpia.eu/media/413006/the-pharmaceutical-industry-in-figures.pdf. [Accessed February 19, 2020].
European Medicines Agency. (2019). EMA now operating from Amsterdam. Retrieved from https://www.ema.europa.eu/en/about-us/brexit-uk-withdrawal-eu/relocation-amsterdam. [Accessed March 12, 2020]
Fama, E. (1970). Efficient capital markets: A review of theory and empirical work. The Journal of Finance, 25(2), 383-417.
GlaxoSmithKline. (n.d). GSK company official site. Retrieved from: https://www.gsk.com/en-gb/home/. [Accessed December 11, 2018].
GlaxoSmithKline Plc. (2019). Fort mill: Mergent. business market research collection. Retrieved from: https://search.proquest.com/docview/1860775690?accountid=29916.
Hashemian-Rahaghi, S., Cheng, F., & Farnaz, A. (2017). Production efficiency and financial performance in pharmaceutical industry: A case of top 24 companies. (August 4, 2017). Available at SSRN Electronic Journal https://ssrn.com/abstract=3437210 or http://dx.doi.org/10.2139/ssrn.3437210.
Hens, T., & Meier, A. (2015). Behavioral finance: The psychology of investing. White Paper, Credit Suisse Group, USA. Retrieved from: https://www.credit-suisse.com. [Accessed February 19, 2019].
Hoovers. (n.d). Hoover's company profiles. Retrieved from: https://www.hoovers.com/. [Accessed December 11, 2018].
Jorion, P., & Goetzmann, W. N. (1999). Global stock markets in the twentieth century. The Journal of Finance, 54(3), 953-980.Available at: https://doi.org/10.1111/0022-1082.00133.
Kahneman, D., & Tversky, A. (1979). Prospect theory: An analysis of decision under risk. Econometrica, 47(2), 263-291.
Kazzazi, F., Pollard, C., Tern, P., Ayuso-Garcia, A., Gillespie, J., & Thomsen, I. (2017). Evaluating the impact of Brexit on the pharmaceutical industry. Journal of Pharmaceutical Policy and Practice, 10(1), 1-12.Available at: https://doi.org/10.1186/s40545-017-0120-z.
Kollewe, J., & Scruton, P. (2019). What are Brexit contingency plans for pharmaceutical industry?. The Guardian. Retrieved from https://www.theguardian.com/politics/2019/feb/19/what-are-brexit-contingency-plans-for-pharmaceutical-industry. [Accessed February 3, 2019].
Lauerman, J., & Ring, S. (2020). U.S. Raises ante in vaccine race with $1.2 Billion for Astra, Bloomberg. Retrieved from: https://www.bloomberg.com/news/articles/2020-05-21/astrazeneca-gets-1-billion-from-u-s-to-make-oxford-vaccine. [Accessed June 2, 2020].
London Stock Exchange. (2020). Agreement to supply Europe with COVID-19 vaccine. Retrieved from: https://www.londonstockexchange.com/news-article/AZN/agreement-to-supply-europe-with-covid-19-vaccine/14576792. [Accessed June 2, 2020].
Malkiel, B. G. (1973). A random walk down wall street. New York: W. W. Norton & Co.
Markovitch, D. G., Steckel, J. H., & Yeung, B. (2005). Using capital markets as market intelligence: Evidence from the pharmaceutical industry. Management Science, 51(10), 1467-1480.
McKee, M., & Martin, J. (2016). How Brexit will affect healthcare, science and research. The Pharmaceutical Journal, 296.
Nicholls, A. (2016). SmartViews: Brexit - What’s next for pharma? Retrieved from http://www.pharmatimes.com/magazine/2016/july_2016/smartviews_brexit_-_whats_next_for_pharma. [Accessed October 12, 2019].
Novartis, A. (2019). Fort Mill: Mergent. Retrieved from: https://search.proquest.com/docview/1860781825?accountid=29916.
Novartis, A. (n.d). Novartis company official website. Retrieved from: https://www.novartis.com/. [Accessed December 11, 2018].
NSF International. (2017). Brexit implications for the UK pharmaceutical industry. York, UK: NSF.
Papastavrou, E., Tsangari, H., Karayiannis, G., Papacostas, S., Efstathiou, G., & Sourtzi, P. (2011). Caring and coping: The dementia caregivers. Aging & Mental Health, 15(6), 702-711.Available at: https://doi.org/10.1080/13607863.2011.562178.
Partington, R. (2019). How has Brexit vote affected the UK economy? October verdict. The Guardian. Retrieved from https://www.theguardian.com/business/2019/oct/25/how-has-brexit-vote-affected-uk-economy-october-verdict. [Accessed February 3, 2020].
Redl, C. (2017). The impact of uncertainty shocks in the United Kingdom. Bank of England Staff Working Paper No.695.
Rogers, L., & Satchell, S. (1991). Estimating variance from high, low and closing prices. The Annals of Applied Probability, 1(4), 504-512.Available at: https://doi.org/10.1214/aoap/1177005835.
Rogers, L. C., Satchell, S. E., & Yoon, Y. (1994). Estimating the volatility of stock prices: A comparison of methods that use high and low prices. Applied Financial Economics, 4(3), 241-247.Available at: https://doi.org/10.1080/758526905.
Sattar, S., Hughes, T., & Marshall, J. (2017). The implications of Brexit on the UK Nhs and the UK pharmaceutical industry. Value in Health, 20(9), A703-A704.Available at: https://doi.org/10.1016/j.jval.2017.08.1835.
Schwert, G. W. (2003). Anomalies and market efficiency. In G. Constantinides et al. (Eds.), Handbook of the Economics of Finance (1st ed., Vol. 1, pp. 939-974): Elsevier.
Shefrin, H., & Statman, M. (2000). Behavioral portfolio theory. Journal of Financial and Quantitative Analysis, 35(2), 127-151.
Shiller, R. J. (2003). From efficient markets theory to behavioral finance. Journal of Economic Perspectives, 17(1), 83-104.
Szyszka, A. (2013). Behavioral finance and capital markets: How psychology influences investors and corporations. New York: Palgrave Macmillan.
Tsangari, H. (2007). An alternative methodology for combining different forecasting models. Journal of Applied Statistics, 34(4), 403-421.Available at: https://doi.org/10.1080/02664760701231633.
UK Parliament Publications. (2018). The impact of Brexit on the pharmaceutical sector. Retrieved from https://publications.parliament.uk/pa/cm201719/cmselect/cmbeis/382/38204.htm. [Accessed May 17, 2019].
This study received no specific financial support.
The authors declare that they have no competing interests.
Both authors contributed equally to the conception and design of the study.